Morphine/oprelvekin interactionFirst report of an interaction, leading to respiratory depression and sedation: case report

被引：0
作者：
机构：
来源：
Reactions Weekly | 2008年 / 1231卷 / 1期
关键词：
Morphine; Phenobarbital; Amitriptyline; Respiratory Depression; Dapsone;
D O I：
10.2165/00128415-200812310-00065
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：22 / 22
相关论文
共 50 条
[21]   Ethylmorphine hydrochlorideFatal respiratory insufficiency and sedation in an infant: case report [J].
Reactions Weekly, 2010, 1320 (1) :23-23
[22]   Morphine overdoseSomnolence, respiratory depression, hypotension, pruritus and nausea following inadvertent intrathecal administration: case report [J].
Reactions Weekly, 2003, 941 (1) :12-12
[23]   Increased Susceptibility to Postoperative PCA Morphine-Induced Respiratory Depression in a Patient with an Undiagnosed Traumatic Porencephalic Cyst - A Case Report [J].
Petrisor, Cristina ;
Tranca, Sebastian ;
Cordos, Andreea ;
Bintintan, Vasile .
JOURNAL OF CRITICAL CARE MEDICINE, 2019, 5 (02) :66-70
[24]   Morphine/oxycodone overdoseConsciousness disorders and respiratory insufficiency: case report [J].
Reactions Weekly, 2008, 1213 (1) :25-25
[25]   Morphine overdoseAcute respiratory distress in an elderly patient: case report [J].
Reactions Weekly, 2009, 1257 (1) :31-32
[26]   Cyclosporin interactionInteraction with concomitant morphine leading to neurological disorders: case report [J].
Reactions Weekly, 2000, 821 (1) :7-7
[27]   Paroxetine interactionInteraction with concomitant morphine and ondansetron leading to delirium?: case report [J].
Reactions Weekly, 1999, 781 (1) :10-10
[28]   LorazepamNeurological and respiratory depression in an elderly patient: case report [J].
Reactions Weekly, 2012, 1415 (1) :32-32
[29]   MethadoneConsciousness disorders, miosis and respiratory depression?: case report [J].
Reactions Weekly, 2009, 1268 (1) :22-22
[30]   Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report [J].
Xin, Zhijun ;
Wang, Ning ;
Wang, Huaizhou .
CURRENT DRUG SAFETY, 2024, 19 (02) :277-281
12345